Republic of Korea vs Netherlands: Share of adolescent girls vaccinated against human papillomavirus
Republic of Korea
65.0%
in 2024
Netherlands
65.0%
in 2024
Republic of Korea rank
38th
Netherlands rank
38th
Share of adolescent girls vaccinated against human papillomavirus over time
- Republic of Korea
- Netherlands
How they compare
Republic of Korea currently reports 65.0% against 65.0% in Netherlands, a difference of 0.0%.
The two have swapped places 4 times across 7 shared years of data; in 2018 it was Netherlands ahead.
Republic of Korea ranks 38th and Netherlands ranks 38th of 74 countries.
Republic of Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 51.5% | 4.0% | Republic of Korea |
| 2020s | 69.4% | 65.8% | 3.6% | Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of adolescent girls vaccinated against human papillomavirus, Republic of Korea or Netherlands?
- Republic of Korea, at 65.0% against 65.0% in Netherlands as of 2024.
- What is the difference in share of adolescent girls vaccinated against human papillomavirus between Republic of Korea and Netherlands?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Netherlands?
- 7 years are reported by both, from 2018 to 2024.
- How do Republic of Korea and Netherlands rank globally for share of adolescent girls vaccinated against human papillomavirus?
- Republic of Korea ranks 38th and Netherlands ranks 38th of 74 countries.
- Where does this data come from?
- WHO & UNICEF (2025) – processed by Our World in Data, published as Share of adolescent girls vaccinated against human papillomavirus. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of fifteen-year-old girls who, between the ages of 9 and 14, received their last dose of the human papillomavirus vaccine.